Drug intelligence / Profile preview

florence

Development stage: Phase 2
Modality: Small Molecules
Administration: Oral

Overview

Florence oral suspension is a pharmaceutical agent under investigation for the treatment of Eosinophilic Esophagitis. The drug is administered orally and aims to evaluate its efficacy in reducing eosinophilic infiltration in esophageal biopsies.

Other names: Florence oral suspension

Beyond the preview

Go deeper on florence.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on florence.

Explore the full profile